Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded
- Contract number
- SPE2DB25FJLDE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,159
Award facts
- Contract value 100% obligated
- $14,158.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,158.70 by the Defense Logistics Agency on August 26, 2025, for the supply of Advair HFA 230-21 microgram inhalers in 12-gram units. The contract carries no set-aside designation and is scheduled for completion by August 27, 2025, with performance taking place at the vendor's Park Ridge location. This delivery order was issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026.
The Defense Logistics Agency utilizes this master contract vehicle to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain through consistent contract performance across diverse medical products, from specialty medications to routine pharmaceuticals, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Quick answers
Who was awarded contract SPE2DB25FJLDE?
SPE2DB25FJLDE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FJLDE worth?
The government has obligated $14,159 on SPE2DB25FJLDE.
Is contract SPE2DB25FJLDE an order under another contract?
Yes. SPE2DB25FJLDE is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLDE competed?
The extent of competition for SPE2DB25FJLDE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award